Stocks
ETFs
Crypto
close
rumor
rumor
Search
⌘K
Screeners
Heatmaps
Trends
News
You're viewing limited data.
Log in
Sign up
close
close
Sign up
Sign up
Log in
Pricing
1 asset
Market news
Type
All
All
Stocks
ETFs
Crypto
Sort
Newest
Newest
Oldest
Published
All
Publisher
All
Assets
ATRA
Asset
Type
All
Stocks
ETFs
Crypto
All
Stocks
ETFs
Crypto
Type
All
All
Sort
Newest
Oldest
Newest
Oldest
Sort
Newest
Newest
Published
All
All
Publisher
All
All
Filter by asset
Stocks
ETFs
Crypto
close
Epstein-Barr Virus Market Set to Witness Growth with Emerging Immunotherapies and Vaccine Pipeline by 2036 – DelveInsight | Atara Biotherapeutics, Pierre Fabre Laboratories, Immunic Therapeutics
Sep 20
Barchart.com
ATRA
Multiple Sclerosis Market Outlook 2036: Growth Trends, Competitive Landscape, and Future Opportunities by 2034 – DelveInsight | Biogen, Immune Response BioPharma, ImCyse, Atara Bio, Emerald Health
Sep 10
Barchart.com
ATRA
Atara Biotherapeutics director Brian Cherry buys nearly $1m in shares
Sep 4
Investing.com
ATRA
Atara Biotherapeutics president and CEO sells $40,882 in shares
Aug 27
Investing.com
ATRA
Atara Biotherapeutics Inc earnings missed by $0.10, revenue fell short of estimates
Aug 12
Investing.com
ATRA
This is the newest page. Registered accounts read further back.
Register to keep reading